
Prometheus Biosciences, Inc.
USD199.92
+0.18 (+0.09%)
CEO
Mark C. McKenna
IPO Date
2021-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$199.68
Prev. Close
$199.74
Day Low
$199.92
Day High
$199.96
52W Low
$23.27
52W High
$199.96
Market Cap
$9.56B
Volume
1.79M
| 18 Apr 2023 |
| Credit Suisse |
| Outperform |
| Neutral |
| downgrade |
| 18 Apr 2023 | Piper Sandler | Overweight | Neutral | downgrade |
| 18 Apr 2023 | Wells Fargo | Overweight | Equal Weight | downgrade |
| 17 Apr 2023 | Guggenheim | Buy | Neutral | downgrade |
| 17 Apr 2023 | Stifel | Buy | Hold | downgrade |
| 6 Mar 2023 | Guggenheim | Buy | Buy | maintain |
| 1 Mar 2023 | Oppenheimer | Outperform | Outperform | maintain |